Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?
过敏性合并症是否会影响阿布昔替尼或度普利尤单抗治疗中重度特应性皮炎患者的疗效和安全性?
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01516-w
Simpson, Eric L; Silverberg, Jonathan I; Geng, Bob; Carrascosa, José-Manuel; Bieber, Thomas; Brunner, Patrick M; Staumont-Sallé, Delphine; Ji, Chao; Biswas, Pinaki; Feeney, Claire; Hernández-Martín, Irene; Rebollo Laserna, Francisco José; Koppensteiner, Herwig